CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 27, 2023
VOTE RESULTS
Ordinary Resolutions
NB | Resolution | Result | For | Against | Vote withhold | Total votes | Shares | Percentage of the | Out of vote | Null voting | Quorum | |
share capital | voting | |||||||||||
represented by the | rights | |||||||||||
represented by | rights | |||||||||||
votes cast | ||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | ||||||
Approval of the annual financial statements for the financial year ended December 31, 2022
1 | ||||||||||||||
1 | Carried | 44 957 162 | 99 | 233 303 | 0.52 % | 27 732 | - | 45 190 465 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
.48 % | ||||||||||||||
Approval of the consolidated financial statements for the financial year ended December 31, 2022 | ||||||||||||||
2 | ||||||||||||||
2 | Carried | 44 957 137 | 99.48 % | 233 303 | 0.52 % | 27 757 | - | 45 190 440 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Appropriation of results for the financial year ended December 31, 2022 | ||||||||||||||
3 | ||||||||||||||
3 | Carried | 44 926 569 | 99.41 % | 265 543 | 0.59 % | 26 085 | - | 45 192 112 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Allocation of losses carried forward to the "share premium" account | ||||||||||||||
4 | ||||||||||||||
4 | Carried | 44 957 932 | 99.48 % | 233 808 | 0.52 % | 26 457 | - | 45 191 740 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Review of the agreements considered in articles L. 225-38 et seq. of the Commercial Code | ||||||||||||||
5 | ||||||||||||||
5 | Carried | 38 406 039 | 99.39 % | 233 938 | 0.61 % | 12 433 | - | 38 639 977 | 36 692 873 | 66,013 % | 6 565 787 | 0 | 72.645 % | |
Renewal of the appointment of Mr. Jean-Pierre Garnier | ||||||||||||||
6 | ||||||||||||||
6 | Carried | 42 038 335 | 93.00 % | 3 164 379 | 7.00 % | 15 483 | - | 45 202 714 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
1/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 27, 2023
VOTE RESULTS
Ordinary Resolutions
NB | Resolution | Result | For | Against | Vote | Total votes | Shares | Percentage of the | Out of vote | Null voting | Quorum | ||||||||
share capital | voting | ||||||||||||||||||
withhold | represented by the | rights | |||||||||||||||||
represented by | rights | ||||||||||||||||||
votes cast | |||||||||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | |||||||||||||
Renewal of the appointment of Mr. Laurent Arthaud |
7 | ||||||||||||||
7 | Carried | 43 046 342 | 95.23 % | 2 156 396 | 4.77 % | 15 459 | - | 45 202 738 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Renewal of the appointment of Mr. Pierre Bastid | ||||||||||||||
8 | ||||||||||||||
8 | Carried | 40 673 751 | 92.94 % | 3 091 670 | 7.06 % | 15 483 | - | 43 765 421 | 38 941 867 | 70.059 % | 1 437 293 | 0 | 71.919 % | |
Renewal of the appointment of Mr. Rainer Boehm | ||||||||||||||
9 | ||||||||||||||
9 | Carried | 42 089 019 | 93.11 % | 3 113 719 | 6.89 % | 15 459 | - | 45 202 738 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Appointment of a new director (Mrs Cecile Chartier) | ||||||||||||||
10 | ||||||||||||||
10 | Carried | 44 937 320 | 99.41 % | 268 730 | 0.59 % | 12 147 | - | 45 206 050 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Authorization to the Board of Directors to buy back shares of the Company | ||||||||||||||
11 | ||||||||||||||
11 | Carried | 44 678 742 | 98.84 % | 526 086 | 1.16 % | 13 369 | - | 45 204 828 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
2/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 27, 2023
VOTE RESULTS
Extraordinary Resolutions
NB | Resolution | Result | For | Against | Vote | Total votes | Shares | Percentage of the | Out of vote | Null voting | Quorum | ||||||||
share capital | voting | ||||||||||||||||||
withhold | represented by the | rights | |||||||||||||||||
represented by | rights | ||||||||||||||||||
votes cast | |||||||||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | |||||||||||||
Authorization to be granted to the Board of Directors to reduce the share capital by cancelling shares under the authorizatio n to buy back its own shares |
12 | |||||||||||||||
12 | Carried | 44 880 463 | 99.28 % | 324 279 | 0.72 % | 13 455 | - | 45 204 742 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Amendment of the age limit applicable to the chairman of the Board of Directors - subsequent amendment of the articles of association | |||||||||||||||
13 | |||||||||||||||
13 | Carried | 38 295 611 | 84.72 % | 6 907 819 | 15.28 % | 14 767 | - | 45 203 430 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any oth er securities with cancellation of shareholders' preferential subscription rights in favor of the European Investment Bank (EIB) or of other entities that may | |||||||||||||||
succeed EIB, according to any finance agreement entered or be entered with EIB | |||||||||||||||
14 | |||||||||||||||
14 | Carried | 44 812 227 | 99.13 % | 393 537 | 0.87 % | 12 433 | - | 45 205 764 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any other securities with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (investors with | |||||||||||||||
experience in the health or biotech sector) | |||||||||||||||
15 | |||||||||||||||
15 | Carried | 44 588 540 | 98.63 % | 617 502 | 1.37 % | 12 155 | - | 45 206 042 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any other securities with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (e.g. credit | |||||||||||||||
institution, investment services provider or member of an investment pool guaranteeing the completion of the issue in question), including, as the case may, within the framework of an equity financing program known as "At -the-market" or "ATM" | |||||||||||||||
16 | |||||||||||||||
16 | Carried | 44 570 910 | 98.60 % | 635 132 | 1.40 % | 12 155 | - | 45 206 042 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares or a ny other securities, with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteri stics (industrial | |||||||||||||||
companies, institutions or entities active in the health or biotechnology sector) | |||||||||||||||
17 | |||||||||||||||
17 | Carried | 44 602 515 | 98.66 % | 603 527 | 1.34 % | 12 155 | - | 45 206 042 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
3/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 27, 2023
VOTE RESULTS
Extraordinary Resolutions
NB | Resolution | Result | For | Against | Vote | Total votes | Shares | Percentage of the | Out of vote | Null voting | Quorum | ||||
share capital | voting | ||||||||||||||
withhold | represented by the | rights | |||||||||||||
represented by | rights | ||||||||||||||
votes cast | |||||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | |||||||||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares or a ny other securities with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics in the | |||||||||||||||
framework of an equity or bond financing agreement | |||||||||||||||
18 | |||||||||||||||
18 | Carried | 44 602 475 | 98.66 % | 603 567 | 1.34 % | 12 155 | - | 45 206 042 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to decide on the issuance of ordinary shares to be issued imm ediately or in the future by the Company, with cancellation of the shareholders' preferential subscription rights, to the benefit of a category of persons meeting | |||||||||||||||
specified characteristics within the framework of an equity financing program on the American market known as "At -the-market" or "ATM" | |||||||||||||||
19 | |||||||||||||||
19 | Carried | 44 602 475 | 98.66 % | 603 567 | 1.34 % | 12 155 | - | 45 206 042 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and/ or any other securities, with the shareholders' preferential subscription rights maintained | |||||||||||||||
20 | |||||||||||||||
20 | Carried | 44 869 970 | 99.26 % | 336 332 | 0.74 % | 11 895 | - | 45 206 302 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and/or any other securities, with cancellation of sharehol ders' preferential subscription rights, by way of a public offering (other than the offerings referred to in paragraph | |||||||||||||||
1 of Article L. 411-2 of the French Monetary and Financial Code) | |||||||||||||||
21 | |||||||||||||||
21 | Carried | 44 556 890 | 98.56 % | 649 412 | 1.44 % | 11 895 | - | 45 206 302 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and/or any other securities, with cancellation of the shareholders' preferential subscription rights in the c ontext of an offer referred to in paragraph 1 of Article L. 411-2 | |||||||||||||||
of the French Monetary and Financial Code | |||||||||||||||
22 | |||||||||||||||
22 | Carried | 44 602 475 | 98.66 % | 603 827 | 1.34 % | 11 895 | - | 45 206 302 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
Delegation to the Board of Directors to increase the number of shares to be issued in the event of a capital increase with or without preferential subscription rights | |||||||||||||||
23 | |||||||||||||||
23 | Carried | 44 682 772 | 98.84 % | 523 530 | 1.16 % | 11 895 | - | 45 206 302 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | ||
4/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 27, 2023
VOTE RESULTS
Extraordinary Resolutions
NB | Resolution | Result | For | Against | Vote | Total votes | Shares | Percentage of the | Out of vote | Null voting | Quorum | |||||||||
share capital | voting | |||||||||||||||||||
withhold | represented by the | rights | ||||||||||||||||||
represented by | rights | |||||||||||||||||||
votes cast | ||||||||||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | ||||||||||||||
Overall limitations on the amount of issues made under the Fifteenth resolution to the Twenty-third resolution aforementioned |
24 | ||||||||||||||
24 | Carried | 44 957 035 | 99.45 % | 248 989 | 0.55 % | 12 173 | - | 45 206 024 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Delegation of authority granted to the Board of Directors to increase the capital by incorporation of premiums, reserves, profits or other | ||||||||||||||
25 | ||||||||||||||
25 | Carried | 44 949 687 | 99.43 % | 256 337 | 0.57 % | 12 173 | - | 45 206 024 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Authorization to the Board of Directors to grant options to subscribe for or purchase shares of the Company | ||||||||||||||
26 | ||||||||||||||
26 | Carried | 43 511 983 | 96.25 % | 1 693 781 | 3.75 % | 12 433 | - | 45 205 764 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Authorization to the Board of Directors to proceed with the free allocation of existing and/or new ordinary shares | ||||||||||||||
27 | ||||||||||||||
27 | Carried | 43 701 908 | 96.67 % | 1 503 856 | 3.33 % | 12 433 | - | 45 205 764 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Overall limits on the amount of issues made under the above issues made under the Twenty-sixth and the Twenty-seventh resolution above | ||||||||||||||
28 | ||||||||||||||
28 | Carried | 44 959 774 | 99.46 % | 246 269 | 0.54 % | 12 154 | - | 45 206 043 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
Delegation to the Board of Directors to proceed with an increase in the share capital, the subscription of which would be res erved for the members of a company savings plan established pursuant to Articles L. 3332-1 et seq. of the Labor Code | ||||||||||||||
29 | ||||||||||||||
29 | Rejected | 5 796 401 | 12.83 % | 39 396 224 | 87.17 % | 25 572 | - | 45 192 625 | 40 379 160 | 72.645 % | 0 | 0 | 72.645 % | |
5/5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cellectis SA published this content on 28 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2023 20:48:35 UTC.